Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Accenture
Baxter
Daiichi Sankyo
McKesson
Mallinckrodt
Fuji
Covington
Cantor Fitzgerald
Merck

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,424,078

« Back to Dashboard

Summary for Patent: 5,424,078
Title: Aqueous ophthalmic formulations and methods for preserving same
Abstract:Stabilized chlorine dioxide is a preservative for ophthalmic formulations. The stabilized chlorine dioxide, when employed as a preservative ophthalmic formulations is preferably present in an amount of from about 0.0002 or about 0.002 to about 0.02 weight/volume percent. The aqueous ophthalmic formulations, in addition to the stabilized chlorine dioxide and the water which functions as a vehicle for the formulations, contains an ophthalmically acceptable tonicity component effective to maintain the osmolality of the formulation at least about 200 mOsmol/kg, and a buffer to maintain the pH of the ophthalmic formulation within an acceptable physiological range. A method for preserving aqueous ophthalmic formulations utilizing stabilized chlorine dioxide is also set forth.
Inventor(s): Dziabo; Anthony J. (El Toro, CA), Ripley; Paul S. (Irvine, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:07/694,640
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 5,424,078

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,424,078

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary 896225 ➤ Subscribe
China 1055874 ➤ Subscribe
Germany 68927631 ➤ Subscribe
Denmark 593989 ➤ Subscribe
European Patent Office 0371728 ➤ Subscribe
Spain 2098226 ➤ Subscribe
Hong Kong 1005164 ➤ Subscribe
Canada 2003198 ➤ Subscribe
Hungary T52706 ➤ Subscribe
Australia 4549989 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Julphar
Argus Health
Merck
US Department of Justice
Moodys
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot